Eyeworld Supplements

2019 ASCRS CLINICAL SURVEY | 7 HIGHLIGHTS OF THE 2019 ASCRS CLINICAL SURVEY Inflammation/infection Respondents were asked if they used NSAIDs differently in high risk patients versus standard patients, and 42% said they begin/increase the use of NSAIDs prior to surgery in high risk patients. Additionally, 39% said they increase the use of NSAIDs postoperatively in high risk patients. When asked when they begin antibiotics for routine cataract surgery, 29.2% of respondents said they begin 3 days or earlier preoperatively, while 26.9% said they begin 1 day preop. Speaking specifically about their preferred intraoperative antibiotic injectable agent, 59.5% of respondents preferred moxifloxacin. "I don't find any surprises in these results [for NSAIDs being used in high risk patients versus standard patients]. The vast majority are increasing them in patients who are high risk or beginning them earlier in patients who are high risk. When you look at the numbers, it's almost 80%. I think there's some data that if you've got a patient who's at high risk for inflammation after surgery, if you start the NSAIDs prior and have them on more when you're doing the surgery, there may be a beneficial effect to keeping the inflammation from increasing right after the surgery or during the surgery. "What I think you see [in terms of when to begin antibi- otics for routine cataract surgery] is a spread. It's pretty much an even spread with people who are starting 3 days prior, 1 day prior, and just doing them during the preoperative period. We do antibiotics when the patient is in the preoperative area prior to surgery. The real data that's important is the data that's consis- tently shown the use of povidone-iodine on the eye preoperatively is helpful in sterilizing the surface of the eye. "I think there's a lot of reasons why moxifloxacin is the most commonly chosen antibiotic to use intraoperatively. It has good coverage against the most common bacteria that can cause endophthalmitis. I think one of the other advantages is that it does come in a preservative-free form so that you can inject it safely intracamerally at the conclusion of the case without any worry about preservatives or other materials that can cause inflammation." Nick Mamalis, MD ASCRS Cataract Clinical Committee DO YOU USE NSAIDS DIFFERENTLY IN HIGH RISK PATIENTS VERSUS STANDARD PATIENTS? (Select all that apply.) WHEN DO YOU BEGIN ANTIBIOTICS FOR A ROUTINE CATARACT SURGERY? WHICH IS YOUR PREFERRED INTRAOPERATIVE ANTIBIOTIC INJECTABLE AGENT?

• Cover